We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$41.1M
2
ADBE icon
Adobe
ADBE
+$23M
3
NSC icon
Norfolk Southern
NSC
+$13.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.6M
5
OTIS icon
Otis Worldwide
OTIS
+$6.73M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARNC
851
DELISTED
Arconic Corporation
ARNC
$5.33K ﹤0.01%
180
– –
RLJ.PRA icon
852
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$323M
$5.3K ﹤0.01%
220
– –
BMRN icon
853
BioMarin Pharmaceuticals
BMRN
$11.5B
$5.2K ﹤0.01%
+60
New +$5.65K
RNG icon
854
RingCentral
RNG
$4.05B
$4.91K ﹤0.01%
150
– –
SYF icon
855
Synchrony
SYF
$23.7B
$4.85K ﹤0.01%
+143
New +$4.37K
CAH icon
856
Cardinal Health
CAH
$53.4B
$4.73K ﹤0.01%
50
– –
ASTS icon
857
AST SpaceMobile
ASTS
$16.8B
$4.7K ﹤0.01%
1,000
– –
HMC icon
858
Honda
HMC
$36.5B
$4.55K ﹤0.01%
150
+10
+7% +$282
TAK icon
859
Takeda Pharmaceutical
TAK
$55.1B
$4.49K ﹤0.01%
286
– –
GANX icon
860
Gain Therapeutics
GANX
$74.6M
$4.48K ﹤0.01%
+1,000
New +$4.88K
IEF icon
861
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$4.44K ﹤0.01%
46
– –
OXY.WS icon
862
Occidental Petroleum Corp Warrants
OXY.WS
$33.2B
$4.29K ﹤0.01%
115
-8
-7% -$306
WTW icon
863
Willis Towers Watson
WTW
$27.9B
$4.24K ﹤0.01%
18
– –
GSAT icon
864
Globalstar
GSAT
$10.2B
$4.21K ﹤0.01%
260
+7
+3% +$112
DGT icon
865
State Street SPDR Global Dow ETF
DGT
$607M
$4.06K ﹤0.01%
36
– –
AI icon
866
C3.ai
AI
$1.27B
$4.04K ﹤0.01%
+111
New +$3.13K
IBKR icon
867
Interactive Brokers
IBKR
$40.9B
$3.99K ﹤0.01%
+192
New +$3.79K
AVTR icon
868
Avantor
AVTR
$7.81B
$3.94K ﹤0.01%
192
-64
-25% -$1.29K
SPWR
869
DELISTED
SunPower Corporation Common Stock
SPWR
$3.92K ﹤0.01%
400
– –
PUK icon
870
Prudential
PUK
$36.5B
$3.91K ﹤0.01%
138
– –
ING icon
871
ING
ING
$93.8B
$3.89K ﹤0.01%
289
– –
SCS
872
DELISTED
Steelcase
SCS
$3.85K ﹤0.01%
+500
New +$3.78K
LYB icon
873
LyondellBasell Industries
LYB
$19.5B
$3.77K ﹤0.01%
41
– –
ILMN icon
874
Illumina
ILMN
$29.4B
$3.75K ﹤0.01%
21
– –
TROW icon
875
T. Rowe Price
TROW
$25B
$3.7K ﹤0.01%
33
-200
-86% -$21.9K
33 34
35
36 37

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.